Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q4 EBIT Loss At SEK 14.3 Million

Jan 28 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * Q4 TOTAL NET SALES (INCL. DURABLE GOODS) IN QUARTER
AMOUNTED TO
SEK 60.3 (62.4) MILLION
    * Q4 OPERATING INCOME (EBIT) AMOUNTED TO SEK -14.3 (1.6)
MILLION

Source text for Eikon:  ID:nMFN6nvmq7 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))

Recent news on Xvivo Perfusion AB

See all news